Small Business Innovation Research · Small Business Technology Transfer
Lumen Bioscience, Inc.: SBIR & STTR awards
2 awards worth $3.52M to 1 companies since 2018 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Lumen Bioscience, Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2021 | 0 | 1 | $2.93M |
| 2018 | 1 | 0 | $597.0K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine. · topic NIAID | Lumen Bioscience, Inc. · Washington | Department of Health and Human Services · National Institutes of Health | STTR Phase II | $2.93M | 2021-07-19 |
| Development of a Spirulina-based oral malaria vaccine · topic NIAID | Lumen Bioscience, Inc. · Washington | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $597.0K | 2018-05-17 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.